Clinical trial

Herbal Therapy in Treating Women With Metastatic Breast Cancer

NCT00028977 · University of California, San Francisco, Other · Completed

Key facts

NCT number NCT00028977
Title Herbal Therapy in Treating Women With Metastatic Breast Cancer
Official title A Pilot Safety, Feasibility, Efficacy And Correlative (Phase I/II) Study Assessing Herba Scutellaria Barbatae (HSB) For Metastatic Breast Cancer
Lead sponsor University of California, San Francisco, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 1/Phase 2
Study type Interventional
Conditions Breast Cancer
Intervention type Drug, Other
Interventions herba scutellaria barbata, herba scutellaria Barbatae (HSB)
Enrollment 21
Start date Aug 1, 2001
Primary completion Apr 1, 2006
Completion Apr 1, 2006
First posted Jan 27, 2003
Last update posted Sep 17, 2012
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies